The Phacilitate Special Interest Group Automation Conference will be held from Tuesday, May the 30th to Wednesday, May the 31st, 2017 in Edinburgh, Scotland.
David Sourdive, Ph.D., EVP of Technical Operations at Cellectis, to take part in this event on Tuesday, May the 30th from 10:55 AM to 12:30 PM during the session intitled "When in the allogeneic cell-based therapy R&D process should you invest in automation?", and from 3:50 PM to 5:20 PM during the session intitled "Defining acceptable costs, quality standards and data management systems for cell-based therapy cold chains at genuine commercial scale". He will also take part in the session intitled "How and when will automation enable commercial cell-based manufacturing at the point of care/in hospitals?" on Wednesday, the 31st from 9:30 AM to 11:00 AM for the part 1 and from 2:25 PM to 3:55 PM for part 2.